Published on 03/12/2025

Changeover Waste & Scrap: Reduction Playbooks

In the pharmaceutical industry, effective packaging process validation is critical to ensuring product quality, regulatory compliance, and operational efficiency. One significant concern that arises during the packaging process is the generation of waste and scrap during changeovers. This comprehensive guide aims to address the key aspects of reducing waste and scrap during packaging changeovers, focusing on sealer crimper qualification, label print verification, and the factors influencing continued process verification (CPV).

The Importance of Packaging Process Validation

Packaging process validation is a regulatory requirement aimed at ensuring that packaging processes consistently produce products meeting predetermined specifications and quality attributes. Regulatory entities such as the US FDA, EMA, and MHRA have laid down guidelines highlighting the need for effective validation processes. Packaging validation includes various elements, from sealing and labeling to the management of changeovers and speed adjustments.

Key regulatory references include the FDA guidelines and the EMA’s guidance documents that underscore the need for robust validation protocols to mitigate risks associated with product packaging.

The following sections outline a step-by-step approach to enhance packaging process validation, focusing specifically on changeover waste and scrap reduction.

Step 1: Understanding Changeovers in Pharmaceutical Packaging

Changeovers refer to the process of switching from one product format to another in a manufacturing line. In the context of pharmaceutical packaging, changeovers can lead to significant waste generation, both in raw materials and through production downtime. Changeovers can be categorized based on the equipment type involved, the product being packaged, and the scale of the operation.

Effective management of changeovers is critical for minimizing waste and ensuring smooth transitions between products. This involves:

• Assessing the time required for a changeover, often referred to as the changeover time.
• Identifying the inherent machine settings that require adjustment, including settings for sealer crimper qualification.
• Evaluating the training and competency of operators responsible for conducting changeovers.

Step 2: Implementing Sealer Crimper Qualification

Sealer crimper qualification is an essential aspect of packaging process validation, focusing on the equipment responsible for sealing the product packaging securely. This step is crucial to prevent product contamination and ensure packaging integrity.

Qualification involves several stages: design qualification (DQ), installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ).

Design Qualification (DQ)

During the DQ phase, assess whether the sealing equipment meets the necessary requirements and guidelines, including compliance with ISO standards such as ISO 11607. This process may include evaluating the equipment’s capabilities in meeting specific heat seal parameters and determining the expected output consistency.

Installation Qualification (IQ)

The IQ phase involves verifying that the equipment has been installed correctly according to manufacturer specifications. Ensure proper documentation of environmental controls and safety features, as well as connection to utility and control systems.

Operational Qualification (OQ)

In the OQ phase, create a series of operational tests to verify that the sealer operates correctly at defined parameters. Document the settings for the sealing process, including temperature, dwell time, and pressure. This will be critical during your validation efforts and future operational reference.

Performance Qualification (PQ)

The final phase, PQ, focuses on demonstrating that the equipment performs consistently under real-world production conditions. It is during this step that you will validate the acceptance criteria for the integrity of the seals created by the crimper. Ongoing monitoring during production will be essential in ensuring long-term compliance.

Step 3: Label Print Verification and Compliance

Labeling is a critical component of pharmaceutical packaging that must conform to compliance guidelines from bodies such as the US FDA and EMA. The effectiveness of label print verification is paramount for avoiding major errors that can result in regulatory penalties and product recalls.

Print verification processes should include:

• Utilizing Optical Character Recognition (OCR) technology for reading and verifying all printed text against the original specifications.
• Implementing UDI (Unique Device Identification) standards in label printing to ensure traceability.
• Developing defect libraries that list potential printing errors and defining acceptable forms of variations.

Implement robust testing and visual inspections of label integrity and accuracy, which directly contributes to ensuring UDI compliance and overall product quality.

Step 4: Establishing Line Clearance and Reconciliation Rules

After a changeover, ensuring the line clearance is meticulously conducted is vital for preventing cross-contamination or mix-ups between batches. Line clearance involves a thorough inspection process to confirm that the previous product has been completely removed from the production line. Key elements include:

• Physical inspection of the equipment to ensure no residues from previous products remain.
• Implementing visual markers or controlled access to designate the line as clear for new products.
• Documenting reconciliations at the end of each production run to analyze quantities produced versus quantities expected.

Following these procedures ensures that the risk of changeover-related errors is minimized, further enhancing the overall integrity of the packaging process.

Step 5: Monitoring Continued Process Verification (CPV)

Continued Process Verification is a systematic monitoring approach conducted after validation to ensure consistent product performance and compliance with established specifications. CPV plays a critical role in identifying variability during production that could lead to defects.

To implement CPV effectively, involve the following steps:

• Identify key performance indicators (KPIs) associated with the packaging process, including metrics related to sealing integrity and labeling accuracy.
• Regularly collect and analyze data to identify trends or deviations from expected performance.
• Create feedback loops that help in making immediate adjustments during production runs while also informing future packaging strategies.

Ongoing CPV activities are essential for adhering to both quality and regulatory requirements, such as those highlighted in the EMA guidelines.

Step 6: Utilizing Defect Libraries and Acceptance Criteria

The development of comprehensive defect libraries is essential for identifying, measuring, and documenting packaging errors encountered during the validation and production phases. This information serves as a reference for decision-making in future packaging processes and assists in maturity evaluations of the current operations.

Defect libraries should encompass:

• Common types of defects associated with sealing and labeling processes.
• Correlations between specific defects and operational conditions or changes.
• Acceptance criteria defining acceptable error rates for both seal integrity and label accuracy.

Establishing clear acceptance criteria in line with industry standards, such as those outlined by ISO/IEC 15416 and ISO/IEC 15415, will set the baseline for what constitutes acceptable performance for your packaging processes.

Conclusion: Ensuring Optimal Packaging Process Validation

In conclusion, minimizing changeover waste and scrap is paramount to maintaining efficiency and compliance in pharmaceutical packaging processes. By systematically implementing each of the steps outlined in this guide—understanding changeovers, executing through sealer crimper qualifications, verifying label printing accuracy, ensuring proper line clearance, monitoring through CPV, and utilizing defect libraries—you can optimize your packaging process validation efforts.

These steps not only align with regulatory expectations from the FDA, EMA, and MHRA but also foster operational excellence in continually improving packaging outcomes. The ongoing attention to detail during each of these phases will influence the quality of pharmaceutical products, ensuring they meet the highest standards of safety and efficacy.